HIM
AGIO icon

Hillsdale Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Hillsdale Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.42K Hold
200
– – ﹤0.01% 632
2026
Q1 		$6.77K Hold
200
– – ﹤0.01% 636
2025
Q4 		$5.44K Hold
200
– – ﹤0.01% 640
2025
Q3 		$8.03K Hold
200
– – ﹤0.01% 569
2025
Q2 		$6.65K Hold
200
– – ﹤0.01% 564
2025
Q1 		$5.86K Hold
200
– – ﹤0.01% 560
2024
Q4 		$6.57K Hold
200
– – ﹤0.01% 541
2024
Q3 		$8.89K Hold
200
– – ﹤0.01% 496
2024
Q2 		$8.62K Buy
+200
New +$7.22K ﹤0.01% 482

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Hillsdale Investment Management's AGIO Position: Q2 2026 in Review

Hillsdale Investment Management held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 200 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Hillsdale Investment Management first reported a position in AGIO in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.89K in Q3 2024. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Hillsdale Investment Management held 200 shares of Agios Pharmaceuticals worth $7.42K as of Q2 2026.
  • Hillsdale Investment Management left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Hillsdale Investment Management's portfolio in Q2 2026, its #632 holding.
  • Hillsdale Investment Management first reported a position in Agios Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Hillsdale Investment Management's Agios Pharmaceuticals position peaked at $8.89K in Q3 2024.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.